Beat The Denominator

Consider small-cap biotech CorMedix (CRMD), which is viewed as undervalued after the market misinterpreted its recent strategic acquisition of Melinta. TG Therapeutics (TGTX) offers a compelling growth opportunity with its MS drug Briumvi, which has market exclusivity until 2042 and targets a potential 10x revenue increase by 2030. A recent 20% price drop in AI-powered beauty company Oddity Tech (ODD) may present a buying opportunity, given its strong recurring revenue model. Look into real estate disruptor The Real Brokerage (REAX), which is rapidly gaining market share in a weak housing market and is positioned for significant growth. Finally, watch Hims & Hers (HIMS) for a catalyst from its expected mid-September launch of testosterone and menopause treatments, though an entry below $40 is suggested due to high volatility.

For diversified exposure to the growing digital asset economy, consider the Bitwise Crypto Industry Innovators ETF (BITW), which is presented as a potential benchmark of the future. A top holding in this ETF, MicroStrategy (MSTR), is highlighted as a high-conviction individual stock for its significant Bitcoin holdings and leadership in the space. The core thesis suggests Bitcoin (BTC) itself is a foundational savings technology with massive long-term growth potential as it captures value from traditional assets. The BITW ETF offers a simple way to invest in a basket of key crypto companies, including MSTR, Marathon Digital (MARA), and Coinbase (COIN). This strategy is based on the major investment theme of capital shifting from legacy financial systems to a new, decentralized digital economy.

The recent drop in MicroStrategy (MSTR) following its S&P 500 exclusion is viewed as a buying opportunity for those bullish on Bitcoin and Web3. For long-term growth, consider allocating to a NASDAQ-tracking fund (QQQ) over an S&P 500 fund, as its rules-based system has historically captured innovative companies more effectively. The core long-term investment theme is the rise of Web3 and tokenized stocks, which are expected to attract new pools of global capital. Key companies positioned to lead this trend include MicroStrategy (MSTR) and Coinbase (COIN). Investors can monitor which stocks are being tokenized on major platforms as a signal of future capital flows and potential outperformance.

Consider the current market weakness a buying opportunity for MicroStrategy (MSTR), which is presented as the premier "blue chip" for Bitcoin exposure. The core investment thesis is MSTR's unique ability to perpetually issue its stock to acquire more Bitcoin, creating a long-term growth cycle. A key catalyst to watch is the Federal Reserve meeting on September 17th-18th, as an anticipated rate cut could ignite a new liquidity cycle beneficial for growth assets. Investors are advised to build a long-term position in MSTR equity and avoid using leverage or chasing smaller, riskier crypto stocks. For those seeking income, MSTR's preferred shares like Stride offer a high-yield alternative that could become more attractive post-rate cuts.

Consider an investment in Hims & Hers Health (HIMS), as its high short interest of 35% creates significant potential for a short squeeze on any positive news. A major upcoming catalyst is the rumored launch of a testosterone product, which could happen as soon as September and unlock a large new revenue stream. The market's fear of lawsuits from Eli Lilly (LLY) and Novo Nordisk (NVO) over compounded GLP-1s appears to be overstated, with the legal risk potentially being priced in. While GLP-1s are a key driver, the company's strategy extends to the broader, durable trend of peptide-based medicine. Investors should be prepared for volatility but focus on the long-term growth story and near-term catalysts.

Consider MicroStrategy (MSTR) as a leveraged investment in Bitcoin, as the company is viewed as significantly undervalued. MSTR strategically issues its own stock at a premium to acquire more Bitcoin at an effective discount, creating a powerful compounding effect. This unique strategy generates a "yield" in the form of accumulating Bitcoin faster than simply holding the asset. The analyst is extremely bullish, highlighting the company's history of high annual returns and its potential for long-term growth. For investors seeking aggressive Bitcoin exposure, MSTR may offer a more advantageous position than a direct investment.

MicroStrategy (MSTR) is a high-conviction investment for leveraged Bitcoin exposure, as it strategically uses its stock premium to continuously acquire more BTC. The core bullish thesis is the "MSTR put," the idea that large entities will buy MSTR stock for massive Bitcoin acquisition, justifying its premium valuation. Investors should be prepared for potential short-term price weakness in Bitcoin through mid-September, which may present a buying opportunity. Due to its dominant scale, MSTR is favored over smaller competitors like MetaPlanet for this investment theme. Do not invest in MSTR with the sole expectation of a near-term S&P 500 inclusion, as this is viewed as an unlikely short-term catalyst.

Consider CleanSpark (CLSK) as an undervalued Bitcoin mining stock, currently trading at a low valuation relative to its assets despite efficient, low-cost operations. A major potential catalyst is the AI optionality of its data centers, and investors should watch for any strategic pivot towards AI from the new CEO. This investment is fundamentally a leveraged play on the price of Bitcoin, which is the primary driver of the company's value. The long-term thesis is supported by a bullish outlook on Bitcoin, with some analysts projecting a price of $500,000 to $1 million by 2030. For a less leveraged investment, consider a direct holding in Bitcoin (BTC) itself.

Consider MicroStrategy's preferred stock, STRC, as management plans to increase its dividend to help push the price towards a $99 target. Reaching this price is a key catalyst that would allow the company to issue more shares and accelerate its Bitcoin acquisition strategy. This makes STRC a tactical play on the broader, long-term bullish strategy of its parent company, MSTR. For direct crypto exposure, a short-term bullish outlook is suggested for Bitcoin (BTC), anticipating a potential market recovery. The key timeframe to watch for this potential upward move in Bitcoin is the last two weeks of September.

Consider MetaPlanet (MTPLF) as a compelling investment, as its stock price has fallen to around $6 despite the company more than doubling its Bitcoin holdings in under three months. This price drop has created a significant disconnect between the company's operational success and its stock valuation, presenting a unique entry point. Upcoming catalysts include a September 1st shareholder vote and a planned international share offering, which could collectively raise over $6 billion to aggressively acquire more Bitcoin. This strategy is a leveraged bet on Bitcoin (BTC), which is viewed with bullish sentiment for the second half of the year. The investment is positioned as a long-term hold with the ultimate goal of capitalizing on Bitcoin potentially reaching $1 million.

Consider adding Super Micro Computer (SMCI), a pure-play on liquid cooling for AI data centers, as it is a favorite pick being actively accumulated. NVIDIA (NVDA) is viewed as a core long-term holding with a reasonable valuation for its high growth, making it a better choice than its competitor. Investors should avoid AMD (AMD), which is considered more expensive and has a weaker growth profile compared to the industry leader. For those with a higher risk tolerance, Nebius (NBIS) offers explosive growth but is currently unprofitable, so waiting for a better entry point is advised. Lastly, Micron (MU) presents a potentially cheap investment in AI memory chips, but be mindful of its historically cyclical and volatile stock performance.

Consider Hims & Hers Health (HIMS) as a long-term investment due to its high 34% short interest, creating a significant "short squeeze" opportunity. The company is viewed as a pharmacy disruptor with a potential 10x return over the next 4-5 years, driven by new product launches and international growth. Another high-conviction opportunity is The Real Brokerage (REAX), a fast-growing digital real estate company considered undervalued with 10x potential. REAX is poised to benefit from an improving housing market, especially if expected interest rate cuts begin in September. In contrast, be cautious with Opendoor (OPEN) at its current price due to its recent massive run-up and riskier business model.

MicroStrategy (MSTR) appears to be in the early stages of a rebound that has historically lasted one to three months, presenting a leveraged opportunity on Bitcoin. For a valuation-based trade, consider Marathon Digital (MARA), as its valuation premium tends to bounce quickly when it approaches the 1.0 level. Income-focused investors may find Stride attractive for its high 12.6% yield. Alternatively, Strike offers a unique way to gain exposure to MSTR's upside through its embedded call option feature. Overall, these Bitcoin proxy stocks are currently outperforming Bitcoin, signaling renewed market confidence.

MicroStrategy (MSTR) is presented as a high-conviction, leveraged investment for those bullish on Bitcoin. The company's primary strategy is to sell its own stock at a premium to acquire more Bitcoin, effectively generating a "yield" on its holdings. The recent resumption of its stock offering program is a significant bullish catalyst that enables this accumulation strategy to continue. Investors should monitor MSTR's stock premium, as a sustained value above 1.5 times its underlying assets is key to the thesis. For direct, non-leveraged exposure, the iShares Bitcoin Trust (IBIT) serves as a simpler alternative and a useful benchmark for MSTR's performance.

A specific MicroStrategy perpetual preferred stock offers a compelling dual investment opportunity with a current yield of 8.2%. The primary thesis is a bet on falling interest rates, which could cause the security's price to appreciate from $97 towards a target of $150-$200. This investment also provides long-term upside, as it becomes convertible into MSTR common stock if MSTR's price surpasses $1,000 per share. Unlike traditional bonds, this security is heavily collateralized by MicroStrategy's Bitcoin holdings, providing significant downside protection. This structure allows investors to capture potential gains from both interest rate cuts and MSTR's growth while receiving a steady income.

With the Federal Reserve expected to begin a rate cut cycle, consider growth stocks that benefit from lower borrowing costs. SoFi (SOFI) is a prime beneficiary, poised for significant growth from an anticipated wave of loan refinancing. For real estate exposure, The Real Brokerage (REAX) is presented as an undervalued, high-growth company that should thrive as lower mortgage rates spur more transactions. To gain leveraged exposure to the bullish outlook on Bitcoin (BTC), consider MicroStrategy (MSTR) as a key holding. Finally, residential solar firm Enphase (ENPH) is a strong turnaround candidate, as lower interest rates will make financing solar installations much more affordable for consumers.

Consider buying MicroStrategy (MSTR) on recent weakness as a high-conviction way to gain exposure to Bitcoin. Maintain some cash to capitalize on short-term market volatility, as any significant dips are viewed as buying opportunities. The overall stock market is expected to perform well over a medium-term horizon of three-plus months. Long-term investors may also consider holding Bitcoin directly as a hedge against central bank policies. Finally, it is advised to avoid the real estate sector, as a meaningful recovery is not anticipated until around 2028.

Consider Tesla (TSLA) for its cluster of potential near-term catalysts in Q3, including a major Full Self-Driving (FSD) update and a potential sales surge before the US tax credit expires on September 30th. The recent sell-off in Hims & Hers Health (HIMS) is presented as a buying opportunity, as the market is incorrectly valuing it solely as a GLP-1 weight-loss company. HIMS is positioned as a long-term disruptive telehealth platform with major growth catalysts ahead in menopause treatments and international expansion. For a leveraged, long-term play on Bitcoin, look at MicroStrategy (MSTR), the analyst's largest holding. View any price weakness in MSTR as an opportunity to gain exposure to Bitcoin as a hedge against long-term fiat currency debasement.